Physician profile

Hasan Khan

Family Medicine · Houston, TX

NPI 1215270152

$365.23

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$218.88

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $173.20 2024 Therasphere Y90 Glass Microspheres 10 Gbq
Medtronic Vascular, INC. $52.81 2019
Novartis Pharmaceuticals Corporation $29.74 2022
Pfizer INC. $29.19 2024
Amarin Pharma, INC. $23.40 2019
Exact Sciences Corporation $16.49 2024 Cologuard Collection Kit
Boehringer Ingelheim Pharmaceuticals, INC. $14.03 2022
Abbott Laboratories $13.85 2021
Merck Sharp & Dohme LLC $12.52 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hasan Khan

$365.23

in general payments reported 2019-2025

Years
2019-2024
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/1385637/hasan-khan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.